Amexdrug
(OTC) AXRX
Amexdrug Financials at a Glance
Market Cap
$33,900
Revenue (TTM)
$3.03M
Net Income (TTM)
$6.77K
EPS (TTM)
$0.00
P/E Ratio
2.00
Dividend
$0.00
Beta (Volatility)
24.18 (High)
Dividend
$0.00
Beta (Volatility)
24.18 (High)
Price
$0.00
Volume
11
Open
$0.00
Price
$0.00
Volume
11
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
24.18 (High)
Price
$0.00
Volume
11
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
AXRX News
AXRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Amexdrug
Industry
Healthcare Providers and Services
Sector
Health CareCEO
Jack N. Amin
Website
www.amexdrug.comHeadquarters
Commerce, CA 90040, US
AXRX Financials
Key Financial Metrics (TTM)
Gross Margin
33%
Operating Margin
3%
Net Income Margin
-0%
Return on Equity
1%
Return on Capital
4%
Return on Assets
-0%
Earnings Yield
50.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$33.90K
Shares Outstanding
169.41M
Volume
11
Short Interest
0.00%
Avg. Volume
0
Financials (TTM)
Gross Profit
$1.15M
Operating Income
$136.79K
EBITDA
$136.79K
Operating Cash Flow
$27.49K
Capital Expenditure
$0.00
Free Cash Flow
$27.49K
Cash & ST Invst.
$1.70M
Total Debt
$431.32K
Amexdrug Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$700.75K
-12.6%
Gross Profit
$199.28K
-36.2%
Gross Margin
28.44%
N/A
Market Cap
$33.90K
N/A
Market Cap/Employee
$3.77K
N/A
Employees
9
N/A
Net Income
$16.62K
-271.3%
EBITDA
$1.60K
-94.1%
Quarterly Fundamentals
Net Cash
$1.27M
+7.8%
Accounts Receivable
$151.53K
-24.0%
Inventory
$529.80K
+28.1%
Long Term Debt
$431.32K
+20.1%
Short Term Debt
$0.00
N/A
Return on Assets
-0.27%
N/A
Return on Invested Capital
4.27%
N/A
Free Cash Flow
$146.60
N/A
Operating Cash Flow
$146.60
N/A